Related Experiment Videos
[The pathogenesis of psoriasis]
Vestnik Dermatologii I Venerologii
|January 1, 1990
Summary
Ildamen improves psoriasis in patients with cardiovascular diseases by stimulating skin beta-adrenoreceptors. This study confirms beta-adrenoreceptors
Area of Science:
- Dermatology
- Cardiology
- Pharmacology
Context:
- Psoriasis is a chronic inflammatory skin condition.
- Cardiovascular diseases (CVDs) are common comorbidities in psoriasis patients.
- The role of the sympathetic nervous system in psoriasis is increasingly recognized.
Purpose:
- To investigate the therapeutic effect of Ildamen on psoriasis in patients with CVDs.
- To elucidate the mechanism of action of Ildamen in psoriasis, focusing on skin beta-adrenoreceptors.
Summary:
- Ildamen demonstrated a positive effect on psoriasis course in patients with co-existing cardiovascular diseases.
- The therapeutic action of Ildamen is attributed to its stimulatory effect on skin beta-adrenoreceptors.
- The study provides evidence for the involvement of beta-adrenoreceptors in the pathogenesis of psoriasis.
Impact:
- Suggests Ildamen as a potential treatment option for psoriasis in patients with CVDs.
- Highlights the importance of targeting beta-adrenoreceptors for psoriasis management.
- Contributes to understanding the neuro-cutaneous interactions in inflammatory skin diseases.